Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 12;386(19):1855-1857.
doi: 10.1056/NEJMc2201821. Epub 2022 Apr 6.

Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers

Collaborators, Affiliations

Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers

Sarang K Yoon et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

References

    1. Thompson MG, Burgess JL, Naleway AL, et al. Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines. N Engl J Med 2021;385:320-329. - PMC - PubMed
    1. Edwards LJ, Fowlkes AL, Wesley MG, et al. Research on the epidemiology of SARS-CoV-2 in essential response personnel (RECOVER): protocol for a multisite longitudinal cohort study. JMIR Res Protoc 2021;10(12):e31574-e31574. - PMC - PubMed
    1. Lutrick K, Ellingson KD, Baccam Z, et al. COVID-19 infection, reinfection, and vaccine effectiveness in a prospective cohort of Arizona frontline/essential workers: the AZ HEROES research protocol. JMIR Res Protoc 2021;10(6):e28925-e28925. - PMC - PubMed
    1. Thompson MG, Natarajan K, Irving SA, et al. Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of delta and omicron variant predominance — VISION network, 10 States, August 2021–January 2022. MMWR Morb Mortal Wkly Rep 2022;71:139-145. - PMC - PubMed
    1. Accorsi EK, Britton A, Fleming-Dutra KE, et al. Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 omicron and delta variants. JAMA 2022;327:639-651. - PMC - PubMed

Supplementary concepts